We are live on
!
Find out more
ZCA
Zeke Capital Advisors Portfolio holdings
AUM
$1.53B
1-Year Est. Return
17.37%
This Fund
S&P 500
This Quarter
Est. Return
+4.75%
1 Year Est. Return
-17.37%
3 Year Est. Return
+41%
5 Year Est. Return
+67.71%
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
-$13.3M
(-1.2%)
Cap. Flow
-$44.9M
Cap. Flow
% of AUM
-4.23%
Top 10 Holdings %
Top 10 Hldgs %
28.84%
Holding
588
New
29
Increased
171
Reduced
213
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
|
+$4.47M |
| 2 |
Corning
GLW
|
+$1.95M |
| 3 |
NOV
NOV
|
+$1.93M |
| 4 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$1.51M |
| 5 |
Wells Fargo
WFC
|
+$1.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GDEN
Golden Entertainment
GDEN
|
+$14.3M |
| 2 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$13.3M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.14M |
| 4 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$3.76M |
| 5 |
American International
AIG
|
+$2.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.41% |
| 2 | Financials | 13.71% |
| 3 | Technology | 11% |
| 4 | Communication Services | 9.36% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Neurocrine Biosciences
NBIX
$16.8B
| – | – |
-8,495
| Closed | -$748K |
|
577
Nexstar Media Group
NXST
$5.82B
| – | – |
-3,357
| Closed | -$364K |
|
578
Ovintiv
OVV
$17.3B
| – | – |
-2,309
| Closed | -$84K |
|
|
PPL
579
PPL Corp
PPL
$26.5B
| – | – |
-12,927
| Closed | -$410K |
|
580
PVH
PVH
$4B
| – | – |
-2,156
| Closed | -$263K |
|
581
RenaissanceRe
RNR
$13.3B
| – | – |
-5,606
| Closed | -$804K |
|
582
Skyworks Solutions
SWKS
$9.37B
| – | – |
-2,919
| Closed | -$241K |
|
583
Tenaris
TS
$28.9B
| – | – |
-10,589
| Closed | -$299K |
|
584
Ternium
TX
$9.67B
| – | – |
-12,324
| Closed | -$335K |
|
585
Ulta Beauty
ULTA
$22B
| – | – |
-865
| Closed | -$302K |
|
586
YPF
YPF
$206B
| – | – |
-53,279
| Closed | -$746K |
|
|
SIX
587
DELISTED
Six Flags Entertainment Corp.
SIX
| – | – |
-8,741
| Closed | -$431K |
|
|
CLVS
588
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-13,412
| Closed | -$333K |
|
Similar funds
GJIC
SBL
TFS
S
LWAC
SGA
BOTW
PIM
Zeke Capital Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Zeke Capital Advisors held 588 positions worth $1.06B, down 1.2% from $1.08B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Zeke Capital Advisors withdrew a net $44.9M in Q2 2019, closing 25 positions and reducing 213 holdings. Its most notable exit was Schwab Fundamental US Large Company Index ETF, an estimated $13.3M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, down from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Zeke Capital Advisors opened a new position in iShares 3-7 Year Treasury Bond ETF worth $1.53M.
- Zeke Capital Advisors's largest Q2 2019 buy was iShares 3-7 Year Treasury Bond ETF: 12,208 shares worth $1.53M.
- Zeke Capital Advisors added most to Zynerba Pharmaceuticals, Inc in Q2 2019, an estimated $4.47M increase.
- Zeke Capital Advisors's biggest Q2 2019 reduction was Golden Entertainment, cutting an estimated $14.3M.
- Zeke Capital Advisors fully exited Schwab Fundamental US Large Company Index ETF in Q2 2019, selling an estimated $13.3M.
- Zeke Capital Advisors's ten largest holdings make up 29% of its $1.06B portfolio in Q2 2019.
- Zeke Capital Advisors opened 29 new positions and closed 25 in Q2 2019.
- Zeke Capital Advisors's portfolio value fell 1.2% quarter-over-quarter to $1.06B.
Based on Zeke Capital Advisors's 13F filing for Q2 2019, filed 24 Jul 2019.